Loading...
OTCMLNDZF
Market cap8mUSD
Jan 02, Last price  
0.10USD
Name

Salona Global Medical Device Corp

Chart & Performance

D1W1MN
OTCM:LNDZF chart
P/E
P/S
0.19
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
16.81%
Rev. gr., 5y
81.88%
Revenues
63m
+58.13%
359,0122,102,6173,944,4083,939,0693,146,866352,130-33,54718,312,26939,605,17962,627,451
Net income
-16m
L-18.21%
-922,249-3,091,383-8,661,597-8,059,642-760,569-2,380,958-2,667,423-4,372,019-19,075,686-15,602,915
CFO
-919k
L-7.47%
803,822-20,698,7793,544,1413,075,5274,000,989-128,047-975,174-3,703,879-993,077-918,908
Dividend
May 24, 20170.0055 USD/sh
Earnings
Mar 25, 2025

Profile

Salona Global Medical Device Corporation, through its subsidiaries, engages in the production and sale of medical devices and products in the United States. The company's medical devices are used for pain management, cold and hot therapy, transcutaneous electronic nerve and neuromuscular electrical stimulation, pulsed electromagnetic field technology, and ultrasound therapy. It also offers wearable technology and products that are used to enhance physical stability. The company was formerly known as Brattle Street Investment Corp. and changed its name to Salona Global Medical Device Corporation in December 2020. Salona Global Medical Device Corporation was incorporated in 2013 and is headquartered in Del Mar, California.
IPO date
Mar 28, 2014
Employees
144
Domiciled in
US
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122022‑022021‑022020‑022019‑022018‑022017‑022016‑022015‑02
Income
Revenues
62,627
242.00%
39,605
-118,158.78%
18,312
-54,686.90%
Cost of revenue
64,250
18,078
Unusual Expense (Income)
NOPBT
(1,623)
39,605
234
NOPBT Margin
100.00%
1.28%
Operating Taxes
57
3,761
(102)
Tax Rate
9.50%
NOPAT
(1,680)
35,844
335
Net income
(15,603)
256.88%
(19,076)
615.14%
(4,372)
63.90%
Dividends
Dividend yield
Proceeds from repurchase of equity
4,262
BB yield
Debt
Debt current
18,007
5,917
Long-term debt
14,593
575
8,796
Deferred revenue
Other long-term liabilities
34,772
Net debt
31,681
(1,354)
6,656
Cash flow
Cash from operating activities
(919)
(993)
(3,704)
CAPEX
(203)
(767)
(55)
Cash from investing activities
(1,519)
(6,717)
(4,618)
Cash from financing activities
825
466
3,935
FCF
(9,860)
24,663
(5,067)
Balance
Cash
919
1,928
8,057
Long term investments
Excess cash
7,141
Stockholders' equity
(9,142)
7,259
6,168
Invested Capital
37,836
52,050
17,518
ROIC
128.76%
3.17%
ROCE
76.09%
0.92%
EV
Common stock shares outstanding
73,472
54,841
43,627
Price
Market cap
EV
EBITDA
862
41,775
1,076
EV/EBITDA
Interest
2,640
388
Interest/NOPBT
165.97%